Once rampant in Philly's drug supply, xylazine is now on the decline after a statewide crackdown, experts tell Axios. Why it ...
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results